Literature DB >> 20052497

The effect of landiolol on cerebral blood flow in patients undergoing off-pump coronary artery bypass surgery.

Koji Goto1, Satoshi Hagiwara, Seigo Hidaka, Shunsuke Yamamoto, Junya Kusaka, Norihisa Yasuda, Chihiro Shingu, Takayuki Noguchi.   

Abstract

PURPOSE: To examine the effect of landiolol on cerebral blood flow in patients with normal or deteriorated cardiac function.
METHODS: Thirty adult patients who were diagnosed with angina pectoris and who underwent elective off-pump coronary artery bypass surgery were studied. Patients were divided into two groups, one with a preoperative left ventricular ejection fraction (EF) of 50% or higher (normal EF group; n = 15) and the other with an EF of less than 50% (low EF group; n = 15). The mean cerebral blood flow velocity (Vmca) and pulsatility index (PI) in the middle cerebral artery were recorded using transcranial Doppler ultrasonography (TCD). Individual hemodynamic data were obtained using a pulmonary arterial catheter.
RESULTS: In both groups, landiolol produced a significant decrease in heart rate (HR), which then returned to baseline 15 min after administration was completed. A significant decrease in mean arterial pressure occurred in the low EF group, but the decrease was within 30% of the baseline. In the normal EF group, there was no decrease in cardiac index (CI), whereas in the low EF group, CI significantly decreased along with the decrease in HR. There were no significant differences in Vmca and PI between the two groups.
CONCLUSION: Continuous administration of landiolol at a dose of 0.04 mg/kg/min after 1 min rapid i.v. administration at a dose of 0.125 mg/kg/min decreases HR without causing aggravation of CBF during treatment of intraoperative tachycardia in patients with normal and deteriorated cardiac function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20052497     DOI: 10.1007/s00540-009-0849-x

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  26 in total

1.  ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).

Authors:  Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
Journal:  Anesth Analg       Date:  2002-05       Impact factor: 5.108

2.  Beta-blocker exposure is associated with improved survival after severe traumatic brain injury.

Authors:  Bryan A Cotton; Kimberly B Snodgrass; Sloan B Fleming; Robert O Carpenter; Clinton D Kemp; Patrick G Arbogast; John A Morris
Journal:  J Trauma       Date:  2007-01

3.  Beta-blocker use is associated with improved outcomes in adult trauma patients.

Authors:  Saman Arbabi; Eric M Campion; Mark R Hemmila; Melissa Barker; Mary Dimo; Karla S Ahrns; Andreas D Niederbichler; Kyros Ipaktchi; Wendy L Wahl
Journal:  J Trauma       Date:  2007-01

4.  Propranolol and cardiac surgery.

Authors:  J F Viljoen; F G Estafanous; G A Kellner
Journal:  J Thorac Cardiovasc Surg       Date:  1972-11       Impact factor: 5.209

5.  Drug management for coronary revascularization without cardiac standstill: the use of high-dose esmolol.

Authors:  D C Abramson; E G Pivalizza; L I Gottschalk
Journal:  J Cardiothorac Vasc Anesth       Date:  1995-04       Impact factor: 2.628

6.  The effect of hemodilution on cerebral blood flow velocity in anesthetized patients.

Authors:  N Bruder; B Cohen; D Pellissier; G François
Journal:  Anesth Analg       Date:  1998-02       Impact factor: 5.108

7.  Cerebral arterial diameters during changes in blood pressure and carbon dioxide during craniotomy.

Authors:  C A Giller; G Bowman; H Dyer; L Mootz; W Krippner
Journal:  Neurosurgery       Date:  1993-05       Impact factor: 4.654

8.  Cardiovascular effects of esmolol in anesthetized humans.

Authors:  P G Menkhaus; J G Reves; I Kissin; J M Alvis; A V Govier; P N Samuelson; W A Lell; C E Henling; E Bradley
Journal:  Anesth Analg       Date:  1985-03       Impact factor: 5.108

9.  Beta-blockers in isolated blunt head injury.

Authors:  Kenji Inaba; Pedro G R Teixeira; Jean-Stephane David; Linda S Chan; Ali Salim; Carlos Brown; Timothy Browder; Elizabeth Beale; Peter Rhee; Demetrios Demetriades
Journal:  J Am Coll Surg       Date:  2007-11-26       Impact factor: 6.113

10.  Use of propranolol to control rate-pressure product during cardiac anesthesia.

Authors:  A M Safwat; J A Reitan; G R Misle; E J Hurley
Journal:  Anesth Analg       Date:  1981-10       Impact factor: 5.108

View more
  1 in total

Review 1.  Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.